{"lab":{"_id":"69ad52a3de79e566650fb11d","accr_number":"AB 108","country":"PL","accr_body":"PCA","address":"ul. Księcia Ziemowita 53 bud.4, 03-885 Warszawa","categories":["other"],"city":"Warszawa","imported_at":"2026-03-08T10:42:43.265Z","methods_count":14,"name":"POLSKIE LABORATORIUM ANTYDOPINGOWE","parse_status":"parsed","parse_version":2,"pdf_files":["AB_108.pdf"],"scope_summary":"","search_text":"polskie laboratorium antydopingowe ul. księcia ziemowita 53 bud.4, 03-885 warszawa other pharma materials electronics food","status":"active","updated_at":"2026-03-08T14:50:15.546Z","valid_from":"","valid_until":"","website":"","parsed_at":"2026-03-08T14:50:15.546Z","parse_date":"2026-07-17T16:18:51.402Z","parse_source":"m5-mistral-qa","email_confidence":"high","email_mx":true,"email_source":"https://www.antydopinglab.pl/index.php/pl/","fields_of_testing":[{"codes":"C/3, C/22","pl":"Badania chemiczne obiektów i materiałów biologicznych przeznaczonych do badań, wyrobów konsumpcyjnych przeznaczonych dla ludzi","en":"Chemical tests of Biological items and materials for testing, consumer products for humans"}],"issue":{"no":"25","date":"05.03.2026"},"map_coord":[52.269318,21.075374],"map_geo":"nominatim-street","has_en":true,"category_counts":{"other":14},"category_scores":{"other":14},"has_zh":true},"methods":[{"_id":"6a5a55eb9af9f73f3824fdb3","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Obecność wolnych stymulantów i niektórych narkotyków","methodology_en":"Presence of free stimulants and certain narcotic drugs","parameters":[],"parameters_en":[],"technique":"GC/MS","technique_en":"GC/MS","computed":[],"computed_en":[],"activity":"Obecność wolnych stymulantów i niektórych narkotyków\nGC/MS","reference":"Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15) _","norm_bases":["Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15) _"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Obecność wolnych stymulantów i niektórych narkotyków\nGC/MS Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15) _ Mocz ludzki E Obecnosc wolnych stymulantow i niektorych narkotykow\nGC/MS Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15) _","categories":["other"],"row_index":0,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Presence of free stimulants and certain narcotic drugs GC/MS Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15) _","search_zh":"人尿 E Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15) _","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdb4","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Rozróżnianie egzogennych i endogennych steroidów anaboliczno- androgennych","methodology_en":"Differentiation of exogenous and endogenous anabolic-androgenic steroids","parameters":[],"parameters_en":[],"technique":"GC/C/IRMS","technique_en":"GC/C/IRMS","computed":[],"computed_en":[],"activity":"Rozróżnianie egzogennych i endogennych steroidów anaboliczno- androgennych\nGC/C/IRMS","reference":"Procedura badawcza 23 (SOP 23)","norm_bases":["Procedura badawcza 23 (SOP 23)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Rozróżnianie egzogennych i endogennych steroidów anaboliczno- androgennych\nGC/C/IRMS Procedura badawcza 23 (SOP 23) Mocz ludzki E Rozroznianie egzogennych i endogennych steroidow anaboliczno- androgennych\nGC/C/IRMS Procedura badawcza 23 (SOP 23)","categories":["other"],"row_index":1,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Differentiation of exogenous and endogenous anabolic-androgenic steroids GC/C/IRMS Procedura badawcza 23 (SOP 23)","search_zh":"人尿 E Procedura badawcza 23 (SOP 23)","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdb5","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Rozróżnianie egzogennych i endogennych steroidów anaboliczno- androgennych","methodology_en":"Differentiation of exogenous and endogenous anabolic-androgenic steroids","parameters":[],"parameters_en":[],"technique":"GC/C/IRMS/MS","technique_en":"GC/C/IRMS/MS","computed":[],"computed_en":[],"activity":"Rozróżnianie egzogennych i endogennych steroidów anaboliczno- androgennych\nGC/C/IRMS/MS","reference":"Procedura badawcza 23 (SOP 23)","norm_bases":["Procedura badawcza 23 (SOP 23)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Rozróżnianie egzogennych i endogennych steroidów anaboliczno- androgennych\nGC/C/IRMS/MS Procedura badawcza 23 (SOP 23) Mocz ludzki E Rozroznianie egzogennych i endogennych steroidow anaboliczno- androgennych\nGC/C/IRMS/MS Procedura badawcza 23 (SOP 23)","categories":["other"],"row_index":2,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Differentiation of exogenous and endogenous anabolic-androgenic steroids GC/C/IRMS/MS Procedura badawcza 23 (SOP 23)","search_zh":"人尿 E Procedura badawcza 23 (SOP 23)","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdb6","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Obecność substancji dopingujących","methodology_en":"Presence of doping substances","parameters":[],"parameters_en":[],"technique":"GC/MS/MS","technique_en":"GC/MS/MS","computed":[],"computed_en":[],"activity":"Obecność substancji dopingujących\nGC/MS/MS","reference":"Procedura badawcza 35 (SOP 35) _ Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15)","norm_bases":["Procedura badawcza 35 (SOP 35) _ Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Obecność substancji dopingujących\nGC/MS/MS Procedura badawcza 35 (SOP 35) _ Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15) Mocz ludzki E Obecnosc substancji dopingujacych\nGC/MS/MS Procedura badawcza 35 (SOP 35) _ Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15)","categories":["other"],"row_index":3,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Presence of doping substances GC/MS/MS Procedura badawcza 35 (SOP 35) _ Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15)","search_zh":"人尿 E Procedura badawcza 35 (SOP 35) _ Procedura badawcza 14 (SOP 14) _ Procedura badawcza 15 (SOP 15)","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdb7","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Oznaczanie ciężaru właściwego","methodology_en":"Determination of specific gravity","parameters":[],"parameters_en":[],"technique":"metoda refraktometryczna","technique_en":"refractometric method","computed":[],"computed_en":[],"activity":"Oznaczanie ciężaru właściwego\nmetoda refraktometryczna","reference":"Procedura badawcza 43 (SOP 43)","norm_bases":["Procedura badawcza 43 (SOP 43)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Oznaczanie ciężaru właściwego\nmetoda refraktometryczna Procedura badawcza 43 (SOP 43) Mocz ludzki E Oznaczanie ciezaru wlasciwego\nmetoda refraktometryczna Procedura badawcza 43 (SOP 43)","categories":["other"],"row_index":4,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Determination of specific gravity refractometric method Procedura badawcza 43 (SOP 43)","search_zh":"人尿 E Procedura badawcza 43 (SOP 43)","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdb8","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Stężenie morfiny","methodology_en":"Morphine concentration","parameters":[],"parameters_en":[],"technique":"metoda GC/MS/MS","technique_en":"GC/MS/MS method","computed":[],"computed_en":[],"activity":"Stężenie morfiny\nmetoda GC/MS/MS","reference":"Procedura badawcza 3a (SOP 3a) _","norm_bases":["Procedura badawcza 3a (SOP 3a) _"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Stężenie morfiny\nmetoda GC/MS/MS Procedura badawcza 3a (SOP 3a) _ Mocz ludzki E Stezenie morfiny\nmetoda GC/MS/MS Procedura badawcza 3a (SOP 3a) _","categories":["other"],"row_index":5,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Morphine concentration GC/MS/MS method Procedura badawcza 3a (SOP 3a) _","search_zh":"人尿 E Procedura badawcza 3a (SOP 3a) _","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdb9","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Obecność 19-norandrosteronu","methodology_en":"Presence of 19-norandrosterone","parameters":[],"parameters_en":[],"technique":"GC/MS/MS","technique_en":"GC/MS/MS","computed":[],"computed_en":[],"activity":"Obecność 19-norandrosteronu\nGC/MS/MS","reference":"Procedura badawcza 7a (SOP 7a)","norm_bases":["Procedura badawcza 7a (SOP 7a)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Obecność 19-norandrosteronu\nGC/MS/MS Procedura badawcza 7a (SOP 7a) Mocz ludzki E Obecnosc 19-norandrosteronu\nGC/MS/MS Procedura badawcza 7a (SOP 7a)","categories":["other"],"row_index":6,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Presence of 19-norandrosterone GC/MS/MS Procedura badawcza 7a (SOP 7a)","search_zh":"人尿 E Procedura badawcza 7a (SOP 7a)","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdba","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Stężenie salbutamolu","methodology_en":"Salbutamol concentration","parameters":[],"parameters_en":[],"technique":null,"technique_en":null,"computed":[],"computed_en":[],"activity":"Stężenie salbutamolu","reference":"Procedura badawcza 9a (SOP 9a)","norm_bases":["Procedura badawcza 9a (SOP 9a)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Stężenie salbutamolu Procedura badawcza 9a (SOP 9a) Mocz ludzki E Stezenie salbutamolu Procedura badawcza 9a (SOP 9a)","categories":["other"],"row_index":7,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Salbutamol concentration Procedura badawcza 9a (SOP 9a)","search_zh":"人尿 E Procedura badawcza 9a (SOP 9a)","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdbb","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"GC/MS","methodology_en":"GC/MS","parameters":[],"parameters_en":[],"technique":null,"technique_en":null,"computed":[],"computed_en":[],"activity":"GC/MS","reference":"","norm_bases":[],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E GC/MS Mocz ludzki E GC/MS","categories":["other"],"row_index":8,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E GC/MS","search_zh":"人尿 E","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdbc","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"GC/MS/MS","methodology_en":"GC/MS/MS","parameters":[],"parameters_en":[],"technique":null,"technique_en":null,"computed":[],"computed_en":[],"activity":"GC/MS/MS","reference":"","norm_bases":[],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E GC/MS/MS Mocz ludzki E GC/MS/MS","categories":["other"],"row_index":9,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E GC/MS/MS","search_zh":"人尿 E","test_object_zh":"人尿 E"},{"_id":"6a5a55eb9af9f73f3824fdbd","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Stężenie tetrahydrokanabinoli","methodology_en":"Tetrahydrocannabinol concentration","parameters":[{"name":"Stężenie tetrahydrokanabinoli","range":null}],"parameters_en":[{"name":"Tetrahydrocannabinol concentration","range":null}],"technique":"GC/MS","technique_en":"GC/MS","computed":[],"computed_en":[],"activity":"Stężenie tetrahydrokanabinoli\nGC/MS","reference":"Procedura badawcza 10a (SOP 10a)","norm_bases":["Procedura badawcza 10a (SOP 10a)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Stężenie tetrahydrokanabinoli\nGC/MS Procedura badawcza 10a (SOP 10a) Mocz ludzki E Stezenie tetrahydrokanabinoli\nGC/MS Procedura badawcza 10a (SOP 10a)","categories":["other"],"row_index":10,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Tetrahydrocannabinol concentration GC/MS Tetrahydrocannabinol concentration Procedura badawcza 10a (SOP 10a)","search_zh":"人尿 E 四氢大麻酚浓度 四氢大麻酚浓度 Procedura badawcza 10a (SOP 10a)","test_object_zh":"人尿 E","methodology_zh":"四氢大麻酚浓度","parameters_zh":[{"name":"四氢大麻酚浓度","range":null}]},{"_id":"6a5a55eb9af9f73f3824fdbe","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Mocz ludzki E","test_object_en":"Human urine E","methodology":"Stężenie tetrahydrokanabinoli","methodology_en":"Tetrahydrocannabinol concentration","parameters":[{"name":"Stężenie tetrahydrokanabinoli","range":null}],"parameters_en":[{"name":"Tetrahydrocannabinol concentration","range":null}],"technique":"GC/MS/MS","technique_en":"GC/MS/MS","computed":[],"computed_en":[],"activity":"Stężenie tetrahydrokanabinoli\nGC/MS/MS","reference":"Procedura badawcza 10a (SOP 10a)","norm_bases":["Procedura badawcza 10a (SOP 10a)"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Mocz ludzki E Stężenie tetrahydrokanabinoli\nGC/MS/MS Procedura badawcza 10a (SOP 10a) Mocz ludzki E Stezenie tetrahydrokanabinoli\nGC/MS/MS Procedura badawcza 10a (SOP 10a)","categories":["other"],"row_index":11,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human urine E Tetrahydrocannabinol concentration GC/MS/MS Tetrahydrocannabinol concentration Procedura badawcza 10a (SOP 10a)","search_zh":"人尿 E 四氢大麻酚浓度 四氢大麻酚浓度 Procedura badawcza 10a (SOP 10a)","test_object_zh":"人尿 E","methodology_zh":"四氢大麻酚浓度","parameters_zh":[{"name":"四氢大麻酚浓度","range":null}]},{"_id":"6a5a55eb9af9f73f3824fdbf","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Krew ludzka*","test_object_en":"Human blood*","methodology":"Obecność tetrahydrokanabinoli*","methodology_en":"Presence of tetrahydrocannabinols*","parameters":[],"parameters_en":[],"technique":"GC/MS/MS*","technique_en":"GC/MS/MS*","computed":[],"computed_en":[],"activity":"Obecność tetrahydrokanabinoli*\nGC/MS/MS*","reference":"Procedura badawcza 25 (SOP 25* _ | Procedura badawcza 26 (SOP 26)* _","norm_bases":["Procedura badawcza 25 (SOP 25* _","Procedura badawcza 26 (SOP 26)* _"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Krew ludzka* Obecność tetrahydrokanabinoli*\nGC/MS/MS* Procedura badawcza 25 (SOP 25* _ | Procedura badawcza 26 (SOP 26)* _ Krew ludzka* Obecnosc tetrahydrokanabinoli*\nGC/MS/MS* Procedura badawcza 25 (SOP 25* _ | Procedura badawcza 26 (SOP 26)* _","categories":["other"],"row_index":12,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human blood* Presence of tetrahydrocannabinols* GC/MS/MS* Procedura badawcza 25 (SOP 25* _ | Procedura badawcza 26 (SOP 26)* _"},{"_id":"6a5a55eb9af9f73f3824fdc0","lab_id":"69ad52a3de79e566650fb11d","country":"PL","accr_number":"AB 108","accr_body":"PCA","test_object":"Krew ludzka*","test_object_en":"Human blood*","methodology":"Obecność kwasu 4-hydroksybutanowego*","methodology_en":"Presence of 4-hydroxybutanoic acid*","parameters":[],"parameters_en":[],"technique":"metoda GC/MS/MS*","technique_en":"GC/MS/MS method*","computed":[],"computed_en":[],"activity":"Obecność kwasu 4-hydroksybutanowego*\nmetoda GC/MS/MS*","reference":"Procedura badawcza 42 (SOP 42)* | Procedura badawcza 26 (SOP 26)*","norm_bases":["Procedura badawcza 42 (SOP 42)*","Procedura badawcza 26 (SOP 26)*"],"lab_section":null,"lab_section_en":null,"lab_address":null,"regulatory_area":null,"regulatory_area_en":null,"search_text":"Krew ludzka* Obecność kwasu 4-hydroksybutanowego*\nmetoda GC/MS/MS* Procedura badawcza 42 (SOP 42)* | Procedura badawcza 26 (SOP 26)* Krew ludzka* Obecnosc kwasu 4-hydroksybutanowego*\nmetoda GC/MS/MS* Procedura badawcza 42 (SOP 42)* | Procedura badawcza 26 (SOP 26)*","categories":["other"],"row_index":13,"parse_version":3,"parse_source":"m5-mistral-qa","search_en":"Human blood* Presence of 4-hydroxybutanoic acid* GC/MS/MS method* Procedura badawcza 42 (SOP 42)* | Procedura badawcza 26 (SOP 26)*"}],"has_pdf":true}